180 Life Sciences EV/EBIT
What is the EV/EBIT of 180 Life Sciences?
The EV/EBIT of 180 Life Sciences Corp. is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to 180 Life Sciences
What does 180 Life Sciences do?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Companies with ev/ebit similar to 180 Life Sciences
- Asensus Surgical Inc has EV/EBIT of N/A
- Aurelius Minerals has EV/EBIT of N/A
- Pintec Technology Ltd has EV/EBIT of N/A
- Spherix has EV/EBIT of N/A
- DiscovEx Resources has EV/EBIT of N/A
- Superconductor Technologies has EV/EBIT of N/A
- 180 Life Sciences has EV/EBIT of N/A
- Westar Resources has EV/EBIT of N/A
- Chaparral has EV/EBIT of N/A
- Katoro Gold plc has EV/EBIT of N/A
- Synairgen plc has EV/EBIT of N/A
- Graycliff Exploration has EV/EBIT of N/A
- DBV Technologies has EV/EBIT of N/A